Delving into the Latest Updates on TD Vaccines A/S with Synapse

Overview

Development of a Polyvalent Vaccine Against Enterotoxigenic Escherichia Coli (ETEC)Protective Efficacy of the Deletion-Attenuated, Multi-valent ACE527 Against Challenge With a Prototype Strain of Enterotoxigenic E.Coli Expressing LT and ST Enterotoxins and CFA/I (Strain H10407) in Human Challenge Model.

This is a research study about an experimental (investigational) vaccine called ACE527. ACE527 is a vaccine that is being made to prevent disease from a germ called enterotoxigenic Escherichia coli (ETEC). This germ causes diarrhea, largely in children living in developing countries and in travelers to those countries. One purpose of this study is to see if the vaccine is safe and develops an immune response. Another purpose is to see if it prevents people from getting sick when exposed to the ETEC germ. This ETEC germ is also experimental (investigational).

Start Date01 Mar 2010

Sponsor / Collaborator

TD Vaccines A/S

[+2]

NCT00901654 / CompletedPhase 1

A Phase I, Single Center, Double-Blind, Placebo-controlled Dose Finding Clinical Study to Evaluate the Safety and Immunogenicity of the Live Attenuated, Oral Vaccine ACE527

The purpose of this study is to evaluate the safety and immune response to ACE527.

Start Date01 Jun 2009

Sponsor / Collaborator

TD Vaccines A/S

[+2]

NCT00859716 / Unknown statusPhase 2

A Randomized, Double-Blind, Placebo Controlled Vaccination-Challenge Study of ACE393 to Determine Efficacy Against the Symptoms of Moderate to Severe Campylobacter Jejuni Infection in Normal Healthy Volunteers

The purpose of this study is to determine whether ACE393 vaccination can protect against Campylobacteriosis in a challenge model.

Start Date01 Oct 2008

Sponsor / Collaborator

TD Vaccines A/S

[+5]

100 Clinical Results associated with TD Vaccines A/S

Login to view more data

0 Patents (Medical) associated with TD Vaccines A/S

Login to view more data

100 Deals associated with TD Vaccines A/S

Login to view more data

100 Translational Medicine associated with TD Vaccines A/S

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

2

Login to view more data